ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 571,57
0,91%
Dow Jones
38 699,28
0,29%
DAX
18 068,21
0,26%
Brent Oil
83,33
1,47%
Bitcoin
65 969,45
-1,00%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Canadá
  5. TSXV
  6. Medicure Inc (MPH)

  7. Medicure Inc (MPH) Actualités

MPH

Medicure (MPH)

Medicure Inc
De:
Trier par:
 Showing the most relevant articles for your search:TSXV:MPH
DateHeureSourceTitreSymboleSociété
30/08/202313h00InvestorsHub NewsWireMedicure reiterates its commitment to providing exceptional access to its branded pitavastatin (zypitamag) to people living with hivTSXV:MPHMedicure Inc
01/02/202313h00PR Newswire (Canada)MEDICURE ANNOUNCES RESIGNATION OF BOARD MEMBER AND GRANT OF STOCK OPTIONSTSXV:MPHMedicure Inc
24/11/202223h00PR Newswire (Canada)MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER ENDED SEPTEMBER 30, 2022TSXV:MPHMedicure Inc
17/11/202223h00PR Newswire (Canada)MEDICURE TO PRESENT FINANCIAL RESULTS ON NOVEMBER 25, 2022 CALL at 8:30 AM ET FOR QUARTER ENDED SEPTEMBER 30, 2022TSXV:MPHMedicure Inc
26/09/202215h00PR Newswire (Canada)EARLY WARNING NEWS RELEASE - DR. ALBERT D. FRIESEN'S HOLDINGS IN MEDICURE INC.TSXV:MPHMedicure Inc
24/08/202223h00PR Newswire (Canada)MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER ENDED JUNE 30, 2022TSXV:MPHMedicure Inc
17/08/202223h00PR Newswire (Canada)MEDICURE TO PRESENT FINANCIAL RESULTS ON AUGUST 25, 2022 CALL at 8:30 AM ET FOR QUARTER ENDED JUNE 30, 2022TSXV:MPHMedicure Inc
20/06/202223h00PR Newswire (Canada)MEDICURE ANNOUNCES RESULTS OF 2022 AGMTSXV:MPHMedicure Inc
31/05/202201h00PR Newswire (Canada)MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER ENDED MARCH 31, 2022 AND APPOINTMENT OF HAARIS UDDIN AS CHIEF FINANCIAL OFFICERTSXV:MPHMedicure Inc
28/04/202202h00PR Newswire (Canada)MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER AND YEAR ENDED DECEMBER 31, 2021TSXV:MPHMedicure Inc
26/04/202219h00PR Newswire (Canada)MEDICURE TO REPORT FINANCIAL RESULTS FOR YEAR ENDED DECEMBER 31, 2021 ON APRIL 28TH AT 7:30 AM CSTTSXV:MPHMedicure Inc
23/03/202222h00PR Newswire (Canada)MEDICURE ANNOUNCES RESIGNATION OF CHIEF FINANCIAL OFFICER AND SUCCESSION PLANTSXV:MPHMedicure Inc
22/02/202215h00PR Newswire (Canada)Medicure's Subsidiary - Marley Drug to Partner with RxSpark, the Next Generation in Pharmacy Discount Programs, to be its Sole Mail-Order PharmacyTSXV:MPHMedicure Inc
09/02/202215h53PR Newswire (Canada)Medicure Launches E-Commerce Pharmacy Platform - www.marleydrug.com Through its Subsidiary Marley Drug PharmacyTSXV:MPHMedicure Inc
22/11/202123h00PR Newswire (Canada)Medicure Reports Financial Results for Quarter Ended September 30, 2021TSXV:MPHMedicure Inc
22/11/202115h00PR Newswire (Canada)Medicure Plans To Launch Innovative E-Commerce Pharmacy Platform Offering Hundreds of Medications Directly To Millions of AmericansTSXV:MPHMedicure Inc
04/11/202122h00PR Newswire (Canada)Medicure Announces that the Shortened AGGRASTAT® Versus INTEGRILIN® in Percutaneous Coronary Intervention (SAVI-PCI) Study has Met its Primary EndpointTSXV:MPHMedicure Inc
27/08/202123h00PR Newswire (Canada)Medicure Reports Financial Results for the Second Quarter Ended June 30, 2021TSXV:MPHMedicure Inc
30/07/202114h00PR Newswire (Canada)Medicure Announces Grant of Stock OptionsTSXV:MPHMedicure Inc
24/06/202123h01PR Newswire (Canada)Medicure Announces Appointment of David Gurvey as Chief Financial OfficerTSXV:MPHMedicure Inc
10/05/202123h30PR Newswire (Canada)Medicure Reports Financial Results for Quarter Ended March 31, 2021TSXV:MPHMedicure Inc
05/05/202121h03PR Newswire (Canada)Medicure 2020 Annual and Q1 2021 Results and Conference Call DateTSXV:MPHMedicure Inc
28/04/202123h01PR Newswire (Canada)Medicure Announces Resignation of Chief Financial Officer and Succession PlanTSXV:MPHMedicure Inc
21/04/202100h00PR Newswire (Canada)Medicure Reports Financial Results for Quarter and Year Ended December 31, 2020TSXV:MPHMedicure Inc
30/03/202101h26PR Newswire (Canada)Medicure to Participate in Renmark's Virtual Non-Deal Roadshow Series on Tuesday, March 30, 2021TSXV:MPHMedicure Inc
08/03/202123h30PR Newswire (Canada)Medicure to Participate in Renmark's Virtual Non-Deal Roadshow Series on Tuesday, March 9, 2021TSXV:MPHMedicure Inc
23/02/202100h17PR Newswire (Canada)Medicure to Participate in Renmark's Virtual Non-Deal Roadshow Series on Tuesday, February 23, 2021TSXV:MPHMedicure Inc
04/02/202123h30PR Newswire (Canada)Medicure To Participate In Renmark's Virtual Non-Deal Roadshow Series on Monday, February 8, 2021TSXV:MPHMedicure Inc
27/01/202123h30PR Newswire (Canada)Medicure Announces Early Completion of Enrollment for iSPASM, a Phase 1/2a Exploratory Clinical Trial of AGGRASTAT® (tirofib...TSXV:MPHMedicure Inc
07/01/202123h30PR Newswire (Canada)Medicure Announces Pivotal Phase 3 Trial IND Filing with FDA for Treatment of Seizures Associated with Pyridox(am)ine 5'-phos...TSXV:MPHMedicure Inc
 Showing the most relevant articles for your search:TSXV:MPH

Dernières Valeurs Consultées

NASDAQ
GOOGL
Alphabet
NYSE
DIS
Walt Disney
EU
MC
Lvmh Moet Hennessy Louis...
EU
BN
Danone
EU
PX4
SBF 120
EU
CS
Axa
EU
ML
Michelin
EU
LR
Legrand
EU
EN
Bouygues
EU
PX1
CAC 40
FTSE
UKX
FTSE 100
NASDAQ
AMZN
Amazon.com
NASDAQ
NVDA
NVIDIA
NYSE
MRK
Merck
EU
HO
Thales
USI
USTECH100
US Tech 100
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés